Business Standard

J&J's single-dose Covid-19 vaccine gets approval for emergency use in India

J&J did not divulge details of when the vaccine will be available in India and what kind of initial volumes can be expected

J&J
Premium

J&J vaccine (Photo: Bloomberg)

Sohini Das Mumbai
India approved US major Johnson & Johnson’s (J&J) single dose Covid-19 vaccine for emergency use on Saturday. The country now has five approved Covid vaccines. 

J&J did not divulge details of when the vaccine will be available in India and what kind of initial volumes can be expected. 

Health Minister Mansukh Mandaviya said in a tweet: “India expands its vaccine basket! Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines.”

This will be the fifth Covid-19 vaccine to get approval after Covishield, Covaxin, Sputnik V and Moderna in India. 

J&J spokesperson confirmed the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in